ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 573,46
-0,78%
Dow Jones
40 211,72
0,00%
DAX
18 492,21
-0,58%
Brent Oil
82,965
-1,63%
Bitcoin
64 016,57
-1,29%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
03/09/201522h18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/09/201517h55Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
01/09/201514h00Business WireTeva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First & Only Transdermal Patch ...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/08/201514h20Dow Jones NewsMylan Holders Approve Perrigo PurchaseNYSE:TEVATeva Pharmaceutical Industries Ltd
26/08/201500h48Dow Jones NewsLilly: U.S. Court Rules in its Favor on Alimta PatentNYSE:TEVATeva Pharmaceutical Industries Ltd
24/08/201516h07PR Newswire (US)Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorisation Applicati...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/08/201514h00Business WireTeva Announces FDA Acceptance of NDA for SD-809 for Treatment in Huntington DiseaseNYSE:TEVATeva Pharmaceutical Industries Ltd
06/08/201523h51Dow Jones NewsAllergan Swings to Loss on Deals-Related Charges -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
06/08/201520h10Dow Jones NewsPatrick Drahi to Move Altice to the NetherlandsNYSE:TEVATeva Pharmaceutical Industries Ltd.
06/08/201519h30Dow Jones NewsMylan Raises Outlook After Stronger Generics SalesNYSE:TEVATeva Pharmaceutical Industries Ltd
06/08/201514h14Dow Jones NewsAllergan Swings to Loss on Deals-Related Charges -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
06/08/201514h10Dow Jones NewsAllergan Swings to Loss on Deals-Related ChargesNYSE:TEVATeva Pharmaceutical Industries Ltd.
05/08/201515h30Dow Jones NewsAllergan Changes Deal for KytheraNYSE:TEVATeva Pharmaceutical Industries Ltd
05/08/201515h17Dow Jones NewsAllergan Changes Its $2.1 Billion Deal for Kythera to All CashNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201522h15Business WireKILL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Teva ...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201518h01Business WireSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Teva Pharm...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201514h00Business WireTeva and Immuneering Announce Teva’s Purchase of 51% Equity Share of Genomic-Analysis CompanyNYSE:TEVATeva Pharmaceutical Industries Ltd
31/07/201519h22Business WireTeva Secures $33.75 Billion Financing CommitmentNYSE:TEVATeva Pharmaceutical Industries Ltd
30/07/201516h00Dow Jones NewsTeva Profit Falls on Legal ExpensesNYSE:TEVATeva Pharmaceutical Industries Ltd.
30/07/201513h00Business WireTeva Reports Strong Second Quarter 2015 Results and Raises Guidance for Full-Year 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/201514h30Dow Jones NewsMylan Gets European Regulator's Approval for Perrigo DealNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201514h00Business WireTeva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization ApplicationNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201501h48Dow Jones NewsMylan's Leverage to Resist Teva Deal Reveals Shift in RulesNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201516h11Dow Jones NewsTeva to Buy Allergan Generics for $40.5 Billion -- 7th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/07/201515h01Dow Jones NewsTeva to Buy Allergan Generics for $40.5 Billion -- 6th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201515h00Dow Jones NewsU.S. Stock Futures Follow Global Markets LowerNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201514h35Dow Jones NewsTeva to Buy Allergan Generics for $40.5 Billion -- 5th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201514h13Dow Jones NewsTeva to Buy Allergan Generics for $40.5 Billion -- 4th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
27/07/201513h51Dow Jones NewsTeva to Buy Allergan Generics for $40.5 Billion -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201512h42PR Newswire (US)Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug UnitNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
VIV
Vivendi
NYSE
DIS
Walt Disney
EU
BEL20
Bel 20
EU
HO
Thales
EU
ACA
Credit Agricole
EU
MC
Lvmh Moet Hennessy Louis...
EU
PX4
SBF 120
EU
RI
Pernod Ricard
EU
AI
Air Liquide
EU
EN
Bouygues
EU
VK
Vallourec
SPI
SP500
S&P 500
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés